Showing 1 - 13 results of 13 for search 'Johanna G van der Bom', query time: 0.07s
Refine Results
-
1
Prediction of Inhospital Mortality in Critically Ill Patients With Sepsis: Confirmation of the Added Value of 24-Hour Lactate to Acute Physiology and Chronic Health Evaluation IV by Meryem Baysan, MD, Mendi S. Arbous, MD, PhD, Ewout W. Steyerberg, MD, PhD, Johanna G. van der Bom, MD, PhD
Published 2022-09-01
Article -
2
-
3
The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial. by Wiebe C Verra, Joost A van Hilten, Áine Honohan, Erik W van Zwet, Johanna G van der Bom, Rob G H H Nelissen, FIRST-research group
Published 2018-01-01
Article -
4
The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data. by Aukje L Kreuger, Rutger A Middelburg, Erik A M Beckers, Karen M K de Vooght, Jaap Jan Zwaginga, Jean-Louis H Kerkhoffs, Johanna G van der Bom
Published 2018-01-01
Article -
5
Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: a nationwide retrospective cohort study by Ada Gillissen, Thomas van den Akker, Camila Caram-Deelder, Dacia D C A Henriquez, Kitty W M Bloemenkamp, Jos J M van Roosmalen, Jeroen Eikenboom, Johanna G van der Bom, on behalf of the TeMpOH-1 study group
Published 2018-10-01
Article -
6
The effect of tranexamic acid on blood loss and maternal outcome in the treatment of persistent postpartum hemorrhage: A nationwide retrospective cohort study. by Ada Gillissen, Dacia D C A Henriquez, Thomas van den Akker, Camila Caram-Deelder, Merlijn Wind, Joost J Zwart, Jos van Roosmalen, Jeroen Eikenboom, Kitty W M Bloemenkamp, Johanna G van der Bom, TeMpOH-1 study group
Published 2017-01-01
Article -
7
Clinical characteristics of women captured by extending the definition of severe postpartum haemorrhage with ‘refractoriness to treatment’: a cohort study by Dacia D. C. A. Henriquez, Ada Gillissen, Sharissa M. Smith, Roos A. Cramer, Thomas van den Akker, Joost J. Zwart, Jos J. M. van Roosmalen, Kitty W. M. Bloemenkamp, Johanna G. van der Bom, on behalf of the TeMpOH-1 study group
Published 2019-10-01
Article -
8
Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease by Johan Boender, Ferdows Atiq, Marjon H. Cnossen, Johanna G. van der Bom, Karin Fijnvandraat, Joke de Meris, Moniek P. M. de Maat, Karin P. M. van Galen, Britta A. P. Laros-van Gorkom, Karina Meijer, Jeroen Eikenboom, Frank W. G. Leebeek, for the WiN study group*
Published 2021-03-01
Article -
9
Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set by Erna C. vanBalen, Brian O'Mahony, Marjon H. Cnossen, Gerard Dolan, Victor S. Blanchette, Kathelijn Fischer, Deborah Gue, Jamie O'Hara, Alfonso Iorio, Shannon Jackson, Barbara A. Konkle, Diane J. Nugent, Donna Coffin, Mark W. Skinner, Cees Smit, Alok Srivastava, Fred vanEenennaam, Johanna G. van derBom, Samantha C. Gouw
Published 2021-05-01
Article -
10
Hepatitis C virus in hemophilia: Health‐related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study by Cas J. Isfordink, Samantha C. Gouw, Erna C. vanBalen, Shermarke Hassan, Erik A. M. Beckers, Johanna G. van derBom, Michiel Coppens, Jeroen Eikenboom, Kathelijn Fischer, Louise Hooimeijer, Frank W. G. Leebeek, Frits R. Rosendaal, Saskia E. M. Schols, Cees Smit, Lize F. D. vanVulpen, Eveline P. Mauser‐Bunschoten
Published 2021-12-01
Article -
11
Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype by Ferdows Atiq, Johan Boender, Waander L. van Heerde, Juan M. Tellez Garcia, Selene C. Schoormans, Sandy Krouwel, Marjon H. Cnossen, Britta A. P. Laros-van Gorkom, Joke de Meris, Karin Fijnvandraat, Johanna G. van der Bom, Karina Meijer, Karin P. M. van Galen, Jeroen Eikenboom, Frank W. G. Leebeek, for the WiN Study Group*
Published 2022-06-01
Article -
12
Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study by Erna C. van Balen, Shermarke Hassan, Cees Smit, Mariette H. E. Driessens, Erik A. M. Beckers, Michiel Coppens, Jeroen C. Eikenboom, Hélène L. Hooimeijer, Frank W. G. Leebeek, Evelien P. Mauser‐Bunschoten, Lize F. D. van Vulpen, Saskia E. M. Schols, Frits R. Rosendaal, Johanna G. van der Bom, Samantha C. Gouw
Published 2022-08-01
Article -
13
The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A by Ilja Oomen, Ilja Oomen, Marieke Verhagen, Marieke Verhagen, Marieke Verhagen, Mariarosaria Miranda, Peter Allacher, Erik A. M. Beckers, Nicole M. A. Blijlevens, Nicole M. A. Blijlevens, Johanna G. van der Bom, Michiel Coppens, Mariëtte Driessens, Jeroen C. J. Eikenboom, Karin Fijnvandraat, Karin Fijnvandraat, Shermarke Hassan, Shermarke Hassan, Waander L. van Heerde, Waander L. van Heerde, Waander L. van Heerde, H. Louise Hooimeijer, Joop H. Jansen, Paul Kaijen, Frank W. G. Leebeek, Daniëlle Meijer, Helmut Paul, Sanna R. Rijpma, Frits R. Rosendaal, Cees Smit, Cees Smit, Lize F. D. van Vulpen, Jan Voorberg, Jan Voorberg, Saskia E. M. Schols, Saskia E. M. Schols, Samantha C. Gouw, Samantha C. Gouw
Published 2024-02-01
Article